We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter's New Solutions Demonstrated at 2013 AACC Annual Meeting

By LabMedica International staff writers
Posted on 01 Aug 2013
Beckman Coulter (Brea, CA, USA) demonstrated its dedication to advancing and optimizing the lab at the 2013 American Association of Clinical Chemistry (AACC) and Clinical Lab Expo in Houston (TX, USA) from July 30–August 1, 2013.

The Beckman Coulter exhibition booth showcased the company’s latest products in total lab automation, scalable solutions, and small footprint systems, including the new Power Express automation solution which streamlines lab workflow and increases flexibility to ultimately decrease turnaround time. More...
The Power Link, also demonstrated, offers labs the ability to combine an AU680 chemistry analyzer with a DxI immunoassay analyzer to form an entry level automated workcell.

Moreover, the latest addition of the IRIS Diagnostics (Chatsworth, CA, USA) urinalysis portfolio and presentations on the company’s newest troponin I assay, AccuTnI+3 on the Access 2 immunoassay system was demonstrated.

Attendees were given opportunities to view Beckman Coulter's newest cellular analysis systems, high-throughput chemistry analyzers, and clinical information solutions in a unique booth design that exhibits the company’s lab automation for the core, reference, and community hospital lab.

Visitors to Beckman Coulter’s booth have the opportunity to learn from industry experts how the company’s latest diagnostic innovations advance and optimize patient care and hear examples of how Beckman Coulter moves the lab forward by increasing efficiency, productivity, and uptime.

Related Links:
Beckman Coulter
Iris Diagnostics



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Early and effective screening for gestational diabetes mellitus is becoming increasingly important (Photo courtesy of Shutterstock)

First-Trimester Blood Test Accurately Predicts Gestational Diabetes

Gestational diabetes mellitus (GDM) affects many pregnancies and is typically detected midway through pregnancy, often too late to prevent complications. Women diagnosed late face increased risks such... Read more

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.